Fig. 4From: Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participantsEstimated glomerular filtration rate by trial arm at each annual follow-up time (years post-transplant) among patients with a reported serum creatinine value on corresponding OPTN follow-up forms. Basi, basiliximab; eGFR, estimated glomerular filtration rate; rATG, rabbit antithymocyte globulinBack to article page